Global Information
회사소개 | 문의

분석 툴 : 암백신

Cancer Vaccines: Analytical Tool

리서치사 BioSeeker Group AB
발행일 2018년 11월 상품 코드 232960
페이지 정보 영문
가격
US $ 3,950 ₩ 4,500,600 Desktop App plus Online Access to Updates (One Year) - Single User
US $ 11,850 ₩ 13,501,800 Desktop App plus Online Access to Updates (One Year) - Global License


분석 툴 : 암백신 Cancer Vaccines: Analytical Tool
발행일 : 2018년 11월 페이지 정보 : 영문

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

본 데이터베이스는 암백신(Cancer Vaccines) 개발에 관한 리포트 및 데이터베이스로 구성되어 있으며, 기존 약제와 신규 약제의 현황과 전망, 개발 파이프라인 동향, 주요 R&D 기업 활동, 주요 개발 프로젝트 동향 등을 전해드립니다.

1. 본 패키지의 구성

  • 리포트 : "Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline(암백신의 상업화 : 파이프라인 최적화를 위한 의사결정 지원 툴)"
  • 데이터베이스(소프트웨어 애플리케이션) : "Cancer Vaccines: Drug Pipeline Update(암백신 약제 파이프라인)"

2. 본 패키지에 포함되는 내용

  • 기존 약제 및 신규 약제의 발전 분석
  • 암백신 R&D에 활발하게 참여하는 기업 정보
  • 암백신 프로젝트 관련 정보
  • 가장 중요한 임상시험에 관한 데이터
  • 개발 초기 단계 프로젝트에 관한 정보
  • 본 서비스 이용자의 요구에 맞춘 고도 검색 실행이 가능

3. 본 툴에 의한 지원

  • 최첨단 기업, 치료, 신기술 추적 조사
  • 제휴처, 경쟁사의 신속한 확인
  • 분석 향상을 위한 포괄적 체제 구축
  • 암백신 개발 관련 프리젠테이션 작성
  • 새로운 암백신 제품과 의약품 R&D의 중요 영역 확인
KSM 12.03.15

With the first prophylactic cancer vaccine Gardasil approved in 2006 and therapeutic cancer vaccine Sipuleucel-T (Provenge) approved in 2010, cancer vaccines is a proven hot treatment modality which is now turbocharged with the event of immune-checkpoint inhibitors.

Cancer Vaccines: Analytical Tool is the most up to date and comprehensive commercial pipeline review and competitive assessment available on this hot and fast moving area in immune-oncology. This unique product is truly the only one of its kind and is designed to give you a competitive edge in your cancer vaccine drug intelligence.

Your Cancer Vaccines: Analytical Tool is based on two decades of proven methodology in serving clients with interest in:

  • Target Scouting
  • Early & Late Stage Pipeline Analysis
  • Biomarker/Companion Diagnostic Analysis (featured below)
  • Deal & Alliance Analysis
  • Conference surveillance of world leading cancer meetings (featured below)
  • Combination Therapy Analysis (featured below)
  • Clinical Trial Results Analysis
  • Indication Selection & Expansion Analysis
  • First-in-Class Analysis
  • Drug Repositioning
  • Pipeline Analysis by Targeted Pathways
  • Instantly generate drug profiles, drug target profiles and company profiles (including Business Development & Licensing contacts)

Analytical Tools transform your computer's desktop into a high capacity workbench within your area of choice. Even before launching this tool you have already eliminated hundreds of hours of work needed to discover, process and piece together the thousands of sources that our team of oncology dedicated and highly experienced contents specialists have done on your behalf.

Your Cancer Vaccines: Analytical Tool covers more than 363 companies plus partners who are today developing 755 cancer vaccine drugs where of 472 are in active development in cancer across 211 different targets. Any data and/or analysis from the Analytical Tool is yours to keep and data/graphs/tables can be easily exported into Excel/PDF and various graphic formats for mixing with your own proprietary information.

Let our expertise work for you

With a simple point and click interface you can navigate the environment of current development, drill down into specific areas such as ongoing combination trials, biomarker analysis, selected scientific abstracts etc. and generate drug profiles, drug target profiles and company profiles (including Business Development & Licensing contacts). Any analysis generated by you is packed with presentation-ready graphs and tables to use in your reports and presentations.

Your key to access development at the world-leading cancer meetings

The Cancer Vaccines: Analytical Tool is continuously updated according to twelve of the world's most influential meetings in oncology (AACR, ASCO, ASGCT, ASH, CIMT, EHA, EORTC-NCI-AACR, ESMO, SITC and BIO (International, Europe and Asia). If you are not able to attend any of the conference(s) in person, this Analytical Tool ensures that you are not missing out on the important take home messages you need to know about.

Run combination therapy analysis like no other

The Cancer Vaccines: Analytical Tool delivers comprehensive combination therapy analysis, allowing you to analyze combination therapies from multiple perspectives; from a single drug to virtually any cross section of oncology drugs of interest.

Unparalleled biomarker surveillance

We also provide an outstanding oncology clinical biomarker surveillance & analysis, highlighting clinical phenotyping and patient stratification in trials. This analysis is based on our monitoring of the presence and usage of more than 1,000 biomarkers across tens of thousands of cancer clinical trials.

Support and inspiration at your finger-tips

You also have access to a great selection of How-to Training Videos showing best practice approaches to aspects such as competitive pipeline analysis right through to many real world case examples put forward by other users of our Analytical Tools.

A tool to grow with and keep you informed

Unlike a static report which just represents a particular snapshot in time, all of the Analytical Tools come with one year of online access to twice-weekly updates in both contents and features, pipeline alerts and online support etc. You can choose to renew your access to these updates and support on a yearly basis or go over to our industry leading full service platform covering all oncology drug development, 1stOncology.

System Requirements

  • Browser Application (Supports: Internet Explorer, FireFox, Chrome and Safari))
  • Internet access
Back to Top
전화 문의
이용안내
 
BCC Research